Effectiveness of Air Filters in Allergic Rhinitis: A Systematic Review and Meta-Analysis

IF 4.3 2区环境科学与生态学 Q1 CONSTRUCTION & BUILDING TECHNOLOGY

Indoor air Pub Date : 2024-03-15 DOI:10.1155/2024/8847667

Ming-Yang Shih, Hsueh-Wen Hsu, Ssu-Yin Chen, Ming-Jang Su, Wei-Cheng Lo, Chiehfeng Chen

{"title":"Effectiveness of Air Filters in Allergic Rhinitis: A Systematic Review and Meta-Analysis","authors":"Ming-Yang Shih, Hsueh-Wen Hsu, Ssu-Yin Chen, Ming-Jang Su, Wei-Cheng Lo, Chiehfeng Chen","doi":"10.1155/2024/8847667","DOIUrl":null,"url":null,"abstract":"<p>Previous studies have evaluated the effectiveness of air filters in mitigating the symptoms of allergic rhinitis (AR). However, these studies have yielded inconsistent results. This systematic review and meta-analysis was conducted to assess the effectiveness of air filters for patients with AR. For this, we comprehensively searched the PubMed, Embase, and Cochrane Library databases to identify relevant articles. The results are presented in terms of standardized mean difference (SMD) and 95% confidence intervals (CI) values with the fixed-effects model (FEM) and random-effects model (REM). Eight randomized controlled trials were included in our meta-analysis. Of these, three had a parallel design and five had a crossover design. Regarding clinical outcomes, pooled analyses performed using patients’ nighttime and daytime symptom scores revealed SMD values of −0.21 (95% CI: −0.35 to −0.07 (FEM) and −0.35 to −0.08 (REM)) and −0.16 (95% CI: −0.30 to −0.03 (both FEM and REM)), respectively. However, no significant changes were noted in the SMD values when assessing medication use, quality of life (QoL), or peak expiratory flow rate (PEFR). In conclusion, air filters may help alleviate symptoms associated with AR; however, their effects on medication use, QoL, and PEFR appear to be limited. This systemic review and meta-analysis is registered with CRD42022380560.</p>","PeriodicalId":13529,"journal":{"name":"Indoor air","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indoor air","FirstCategoryId":"93","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/8847667","RegionNum":2,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CONSTRUCTION & BUILDING TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Previous studies have evaluated the effectiveness of air filters in mitigating the symptoms of allergic rhinitis (AR). However, these studies have yielded inconsistent results. This systematic review and meta-analysis was conducted to assess the effectiveness of air filters for patients with AR. For this, we comprehensively searched the PubMed, Embase, and Cochrane Library databases to identify relevant articles. The results are presented in terms of standardized mean difference (SMD) and 95% confidence intervals (CI) values with the fixed-effects model (FEM) and random-effects model (REM). Eight randomized controlled trials were included in our meta-analysis. Of these, three had a parallel design and five had a crossover design. Regarding clinical outcomes, pooled analyses performed using patients’ nighttime and daytime symptom scores revealed SMD values of −0.21 (95% CI: −0.35 to −0.07 (FEM) and −0.35 to −0.08 (REM)) and −0.16 (95% CI: −0.30 to −0.03 (both FEM and REM)), respectively. However, no significant changes were noted in the SMD values when assessing medication use, quality of life (QoL), or peak expiratory flow rate (PEFR). In conclusion, air filters may help alleviate symptoms associated with AR; however, their effects on medication use, QoL, and PEFR appear to be limited. This systemic review and meta-analysis is registered with CRD42022380560.

查看原文本刊更多论文

空气过滤器对过敏性鼻炎的疗效：系统回顾与元分析

以往的研究评估了空气过滤器在减轻过敏性鼻炎（AR）症状方面的效果。然而，这些研究得出的结果并不一致。本系统综述和荟萃分析旨在评估空气过滤器对 AR 患者的疗效。为此，我们全面检索了 PubMed、Embase 和 Cochrane 图书馆数据库，以确定相关文章。研究结果采用固定效应模型（FEM）和随机效应模型（REM），以标准化平均差（SMD）和95%置信区间（CI）值表示。我们的荟萃分析纳入了八项随机对照试验。其中，三项采用平行设计，五项采用交叉设计。在临床结果方面，使用患者的夜间和白天症状评分进行的汇总分析显示，SMD 值分别为-0.21（95% CI：-0.35 至-0.07（FEM）和-0.35 至-0.08（REM））和-0.16（95% CI：-0.30 至-0.03（FEM 和 REM））。然而，在评估药物使用情况、生活质量（QoL）或呼气峰流速（PEFR）时，SMD 值没有明显变化。总之，空气过滤器可能有助于缓解与 AR 相关的症状；但其对药物使用、生活质量和呼气峰流速的影响似乎有限。本系统综述和荟萃分析的注册号为 CRD42022380560。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Indoor air 环境科学-工程：环境

CiteScore

10.80

自引率

10.30%

发文量

175

审稿时长

3 months

期刊介绍： The quality of the environment within buildings is a topic of major importance for public health. Indoor Air provides a location for reporting original research results in the broad area defined by the indoor environment of non-industrial buildings. An international journal with multidisciplinary content, Indoor Air publishes papers reflecting the broad categories of interest in this field: health effects; thermal comfort; monitoring and modelling; source characterization; ventilation and other environmental control techniques. The research results present the basic information to allow designers, building owners, and operators to provide a healthy and comfortable environment for building occupants, as well as giving medical practitioners information on how to deal with illnesses related to the indoor environment.